Dysregulated Up-Frameshift Protein 1 Promotes Ulcerative Colitis Pathogenesis Through the TNFR1-NF-κB/MAPKs Pathway
- 156 Downloads
Ulcerative colitis (UC) is an idiopathic colonic mucosal disease, and its pathogenesis has not been fully understood. Up-frameshift protein 1 (UPF1) is a potential molecule for UC predicted by a computational approach.
The present study aimed to validate the underlying mechanism of UPF1 in UC.
UPF1 expression was detected by qRT-PCR, western blotting, and immunohistochemistry in dextran sulfate sodium-induced colitis in mice. To simulate the intestinal inflammation microenvironment, NCM460 human colonic epithelial cells were exposed to a mixture of inflammatory mediators. The potential mechanism involving TNFR1-NF-κB/MAPKs pathway activation was addressed by western blotting, reporter gene assays, and siRNA (siUPF1) or UPF1-expressing plasmid pENTER-transfected cells.
UPF1 was downregulated in colonic epithelial cells of colitic mice, and in vitro, contrary to the mRNA levels of the associated cytokines enhanced in the UPF1 dysregulation group within stimulatory factors, most relevant cytokines were significantly decreased in UPF1 overexpression group. Mechanistically, the increased expression of tumor necrosis factor receptor 1 (TNFR1) was found in NCM460 cells pre-treated with siUPF1, with the activation of IKK/NF-κB and MAPKs pathways, including JNK/AP-1 and P38, but not the ERK1/2 pathway. Moreover, the repression of TNFR1 required the interaction of UPF1 with the promoter.
UPF1, which negatively regulated the transcription of TNFR1, is a novel factor regulating intestinal inflammation. The downregulation of UPF1 activated the TNFR1-dependent NF-κB/MAPKs pathway, and promoting inflammatory responses in colon might act as a causal role in UC.
KeywordsUlcerative colitis (UC) Up-frameshift mutant 1 (UPF1) Tumor necrosis factor receptor 1 (TNFR1) NF-κB/MAPKs pathway
The authors would like to thank Prof. Chaohui Yu for critical inputs on the project. The authors would also like to thank Meng Li, Jianghua Chen and the teachers as well as students of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, for outstanding technical assistance.
HTZ, SJH and MY initiated the study and performed the experiments, data analysis, and manuscript writing. WGC supervised the study and revised the manuscript. CL, XHL, CXL, GDS, HTC, and XWX contributed to the experimental design, data analysis, and manuscript revision. GQX and LHC had full access to all the data in the present study and had final responsibility for the decision to submit for publication. All authors have read and approved the manuscript.
The present study was financially supported by grants from the National Natural Science Foundation of China (No. 81600413) and Natural Science Foundation of Zhejiang Province (LY16H030005).
Compliance with ethical standards
Conflict of interest
The authors declare that no conflicts of interest.
The study was approved by the Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. Informed consent was obtained from each subject prior to the study. The maintenance of mice and all animal experimental procedures were conducted in accordance with the National Institutes of Health (NIH) guidelines. All mouse studies were approved by The Animal Care and Use Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University, in accordance with the Chinese guidelines for the care and use of laboratory animals.
- 11.Bank S, Skytt Andersen P, Burisch J, et al. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort. PLoS ONE. 2014;9:e98815.CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Schweingruber C, Rufener SC, Zund D, Yamashita A, Muhlemann O. Nonsense-mediated mRNA decay - mechanisms of substrate mRNA recognition and degradation in mammalian cells. Biochim Biophys Acta. 1829;2013:612–623.Google Scholar
- 29.Lawson MM, Thomas AG, Akobeng AK. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2006;4:CD005112.Google Scholar
- 31.Melagraki G, Ntougkos E, Rinotas V, et al. Cheminformatics-aided discovery of small-molecule Protein–Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-kappaB Ligand (RANKL). PLoS Comput Biol. 2017;13:e1005372.CrossRefPubMedPubMedCentralGoogle Scholar